[Capecitabine aggravating lentiginosis]

Therapie. 2021 May-Jun;76(3):253-255. doi: 10.1016/j.therap.2020.02.015. Epub 2020 Feb 21.

[Article in French]

Authors

Safa Idoudi¹, Lobna Boussofara², Marwen Belkahla², Nadia Ghariani Fetoui², Najet Ghariani², Colandane Belajouza², Mohamed Denguezli²

Affiliations

¹ Département de dermatologie, hôpital Farhat Hached, 4000 Sousse, Tunisie. Electronic address: safaa.idoudi@gmail.com.
² Département de dermatologie, hôpital Farhat Hached, 4000 Sousse, Tunisie.

PMID: 32169288
DOI: 10.1016/j.therap.2020.02.015

No abstract available

Keywords: Capecitabine; Capécitabine; Hand-foot syndrome; Hyperpigmentation; Lentigine; Lentigines; Peutz-Jeghers; Syndrome main-pied.

Publication types

Letter

MeSH terms

Capecitabine / adverse effects
Humans
Lentigo*

Substances

Capecitabine